Search
for
Sort by
Research 61–90 of 1000+
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- This Month in JAAD: October 2021
- Alopecia areata: from pathophysiology to therapeutic innovation
- Alopecia areata: current concepts
- Baricitinib-Loaded Separable Microneedle Array Patch (S-Map) Based on Hyaluronic Acid for Alopecia Areata Therapy
- Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata
- 26 Characterization of a murine model of aa induced by adoptive transfer of cultured lymph node cells
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Treatments for alopecia areata: a network meta-analysis
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2
- Novel investigational drugs for alopecia areata and future perspectives
- Spotlight in Plastic Surgery: October 2022
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Medicom Conference Report WCD 2023
- Drug news and therapeutic news
- Ann Robinson’s research reviews —12 May 2022
- Hair
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Most Baricitinib Responders Achieved Full Scalp Hair Regrowth: Findings from Adult and Paediatric BRAVE-AA Trials
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials